- ICH GCP
- EU: n kliinisten tutkimusten rekisteri
Viimeisimmät kokeilut
EudraCT Number: 2006-004437-15 | Sponsor Protocol Number: ONC-2006-002 | Start Date: 2006-11-24 | |||||||||||
Sponsor Name: ISTITUTO CLINICO HUMANITAS | |||||||||||||
Full Title: FASE II PROSPECTIVE STUDY BAY-43-90006 IN ADVANCED, METASTATIC SOFT TISSUE SARCOMAS, AFTER ANTRACYCLINE-BASED THERAPY | |||||||||||||
Medical condition: Histologically documented, progressive, advanced or metastatic sarcoma after adjuvant and/or first line antracycline-based regimen | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: IT (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2006-004065-34 | Sponsor Protocol Number: TUD-COFI06-014 | Start Date: 2006-11-24 | ||||||
Sponsor Name: Technical University Dresden | ||||||||
Full Title: Open labeled, multicenter phase I / II study evaluating the dose escalation/ safety of Cetuximab and Oxaliplatin/ 5-FU/FA/ Irinotecan as first-line treatment of metastatic colorectal cancer | ||||||||
Medical condition: first-line treatment of metastatic colorectal cancer | ||||||||
|
||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||
Trial protocol: DE (Completed) | ||||||||
Trial results: (No results available) |
EudraCT Number: 2006-004203-19 | Sponsor Protocol Number: ALS-3-06-A-401 | Start Date: 2006-11-24 | ||||||
Sponsor Name: AIR LIQUIDE Santé INTERNATIONAL | ||||||||
Full Title: Etude de l'efficacité du Kalinox 170 bar lors de la réalisation de biopsies de lésions focales hépatiques | ||||||||
Medical condition: Analgésie - biopsie hépatique percutanée sous échographie pour diagnostic de lésions focales | ||||||||
|
||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||
Trial protocol: FR (Ongoing) | ||||||||
Trial results: (No results available) |
EudraCT Number: 2005-004754-27 | Sponsor Protocol Number: HOE-901/6060 | Start Date: 2006-11-24 | |||||||||||
Sponsor Name: Cardiff University | |||||||||||||
Full Title: Comparison of insulin detemir and insulin glargine in patients with Type 2 diabetes | |||||||||||||
Medical condition: Type 2 Diabetes | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: GB (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2007-003906-89 | Sponsor Protocol Number: 2163/2006 | Start Date: 2006-11-23 | |||||||||||
Sponsor Name: Istituto Fisiologia Clinica, CNR | |||||||||||||
Full Title: Insulin Therapy in non-diabetic patients with Acute Coronary Syndromes: Effect of strict glycemic control on systemic endothelial function, coronary flow reserve, and left ventricular contractility | |||||||||||||
Medical condition: Iperglycemia with Acute Coronary Syndrome | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: IT (Prematurely Ended) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2005-004234-41 | Sponsor Protocol Number: 4102000 | Start Date: 2006-11-23 | |||||||||||
Sponsor Name: Otto-von-Guericke Universität Magdeburg | |||||||||||||
Full Title: Dosisdichte 1st-line Therapie des metastasierten Mammakarzinoms mit Paclitaxel und liposomalem Doxorubicin (Myocet®) | |||||||||||||
Medical condition: metastasiertes Mammakarzinom | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Female | ||||||||||||
Trial protocol: DE (Prematurely Ended) | |||||||||||||
Trial results: View results |
EudraCT Number: 2006-003385-34 | Sponsor Protocol Number: CRU.LUMC.001 | Start Date: 2006-11-23 | |||||||||||
Sponsor Name: Boehringer Ingelheim Pharma GmbH & Co. KG | |||||||||||||
Full Title: The effect of tiotropium-bromide on deep inspiration-induced bronchodilation and airway responsiveness in asthma. | |||||||||||||
Medical condition: 24 patients with mild persistent asthma will participate in the study. All patients will be allergic to one or more airborne allergens, hyperresponsive to histamine (PC20 | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||
Trial protocol: NL (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2006-002676-18 | Sponsor Protocol Number: 26-01 | Start Date: 2006-11-23 | |||||||||||
Sponsor Name: WELEDA AG DEUTSCHLAND | |||||||||||||
Full Title: Randomized, open-label phase 2 study on post-relapse disease-free survival (PRDFS) with the Viscum-album Extract (VA-E) Iscador P or oral Etoposide in spindle-cell bone-sarcoma patients in complete... | |||||||||||||
Medical condition: spindle-cell bone-sarcoma patients in complete remission after surgery for second relapse. | |||||||||||||
|
|||||||||||||
Population Age: Children, Adolescents, Under 18, Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: IT (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2006-002950-32 | Sponsor Protocol Number: 1502 | Start Date: 2006-11-23 | ||||||
Sponsor Name: Gentofte University Hospital | ||||||||
Full Title: Long term effects of DPP-IV inhibitor treatment on the secretion and action of the incretin hormones in patients with type 2 diabetes | ||||||||
Medical condition: Type 2 diabetes diagnosed according to the criteria from WHO | ||||||||
|
||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||
Trial protocol: DK (Completed) | ||||||||
Trial results: (No results available) |
EudraCT Number: 2006-001040-31 | Sponsor Protocol Number: TUD-RELAZA-008 | Start Date: 2006-11-23 | ||||||
Sponsor Name: University of Technology Dresden | ||||||||
Full Title: Treatment of the haematological relapse in patients suffering from acute myeloid leukaemia or myelodysplastic syndrome with 5-Azacytidin (Vidaza®) after hematopoietic stem cell transplantation "REL... | ||||||||
Medical condition: Patients suffering from acute myeloid leukaemia or myelodysplastic syndrome with falling CD34-chimerism or relapse after hematopoietic stem cell transplantation. | ||||||||
|
||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||
Trial protocol: DE (Completed) | ||||||||
Trial results: View results |